Terms: = Uterine cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Treatment
12107 results:
1. Tailoring postoperative management through sentinel lymph node biopsy in low- and intermediate-risk endometrial cancer - the SENTRY clinical trial.
Sorokin P; Novozhilov M; Utkin D; Abduragimova Z; Dudina I; Nikiforchin A; Kulikova S
Klin Onkol; 2024; 38(2):126-133. PubMed ID: 38697821
[TBL] [Abstract] [Full Text] [Related]
2. Metformin for endometrial hyperplasia.
Shiwani H; Clement NS; Daniels JP; Atiomo W
Cochrane Database Syst Rev; 2024 May; 5():CD012214. PubMed ID: 38695827
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
Zhou Y; Wang W; Tang J; Hu K; Zhang F
BMC Cancer; 2024 Apr; 24(1):548. PubMed ID: 38689248
[TBL] [Abstract] [Full Text] [Related]
4. [Effect of COVID-19 pandemics in treatment of cervical cancer: pre/post study].
Arrossi S; Binder F; Ituarte C; Martiarena N; Campanera A; Bárcena M; Paolino M
Medicina (B Aires); 2024; 84(2):236-248. PubMed ID: 38683508
[TBL] [Abstract] [Full Text] [Related]
5. [
Adam JA; Poel E; van Eck Smit BLF; Mom CH; Stalpers LJA; Laan JJ; Kidd E; Stoker J; Bipat S
BMC Cancer; 2024 Apr; 24(1):513. PubMed ID: 38654241
[TBL] [Abstract] [Full Text] [Related]
6. [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
Li X; Gao YH; Yang Z; Ma Y; Liu C; Liu GC; Wang DB
Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):307-319. PubMed ID: 38644277
[No Abstract] [Full Text] [Related]
7. Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries.
Fackler MJ; Pleas M; Li Y; Soni A; Xing D; Cope L; Ali S; Van Le Q; Van Nguyen C; Pham HT; Duong LM; Vanden Berg E; Wadee R; Michelow P; Chen WC; Joffe M; Fjeldbo CS; Lyng H; Sukumar S
Clin Epigenetics; 2024 Apr; 16(1):56. PubMed ID: 38643219
[TBL] [Abstract] [Full Text] [Related]
8. Diagnosis and rescue of malignant hyperthermia induced by anesthesia during radical surgery in a cervical cancer patient using the National Remote Emergency System: A case report.
Xiao Y; Yu R; Gu J
Medicine (Baltimore); 2024 Apr; 103(16):e37699. PubMed ID: 38640306
[TBL] [Abstract] [Full Text] [Related]
9. [Cognition of human papillomavirus and its influencing factors among college students in Shandong province].
Zhang J; Shao SY; Ma YJ; Qin W
Zhonghua Nan Ke Xue; 2023 Sep; 29(9):826-830. PubMed ID: 38639596
[TBL] [Abstract] [Full Text] [Related]
10. Sarcoma of the uterine cervix: experience of a single center.
Yuan H; Li L; Li N; Yao H
World J Surg Oncol; 2024 Apr; 22(1):104. PubMed ID: 38637834
[TBL] [Abstract] [Full Text] [Related]
11. Wavelet scattering transform and entropy features in fluorescence spectral signal analysis for cervical cancer diagnosis.
Deo BS; Nayak S; Pal M; Panigrahi PK; Pradhan A
Biomed Phys Eng Express; 2024 Apr; 10(4):. PubMed ID: 38636479
[TBL] [Abstract] [Full Text] [Related]
12. Pelvic target volume inter-fractional motion during radiotherapy for cervical cancer with daily iterative cone beam computed tomography.
Zeng Z; Zhu J; Wang Z; Wang G; Yan J; Zhang F
Radiat Oncol; 2024 Apr; 19(1):48. PubMed ID: 38622628
[TBL] [Abstract] [Full Text] [Related]
13. Average log change rate of pretreatment squamous cell carcinoma antigen after concurrent chemoradiotherapy in stage IIIC1 cervical squamous cell carcinoma.
Cho O; Chun M; Chang SJ
Sci Rep; 2024 Apr; 14(1):8710. PubMed ID: 38622276
[TBL] [Abstract] [Full Text] [Related]
14. Rel Family Transcription Factor NFAT5 Upregulates COX2 via HIF-1α Activity in Ishikawa and HEC1a Cells.
Okumura T; Raja Xavier JP; Pasternak J; Yang Z; Hang C; Nosirov B; Singh Y; Admard J; Brucker SY; Kommoss S; Takeda S; Staebler A; Lang F; Salker MS
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612478
[TBL] [Abstract] [Full Text] [Related]
15. Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1-2, open-label, multicohort trial.
Oaknin A; Moore K; Meyer T; López-Picazo González J; Devriese LA; Amin A; Lao CD; Boni V; Sharfman WH; Park JC; Tahara M; Topalian SL; Magallanes M; Molina Alavez A; Khan TA; Copigneaux C; Lee M; Garnett-Benson C; Wang X; Naumann RW
Lancet Oncol; 2024 May; 25(5):588-602. PubMed ID: 38608691
[TBL] [Abstract] [Full Text] [Related]
16. Efficacy and safety of BVAC-C in HPV type 16- or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study.
Choi CH; Lee JW; Bae DS; Kang ES; Cho D; Kim YM; Kim K; Kim JW; Kim HS; Kim YT; Lee JY; Lim MC; Oh T; Song B; Jeon I; Park M; Kim WH; Kang CY; Kim BG
Front Immunol; 2024; 15():1371353. PubMed ID: 38605958
[TBL] [Abstract] [Full Text] [Related]
17. The differential expression of AFF3 in cervical cancer and its correlation with clinicopathological features and prognosis.
Zhang Y; Li L; Han Q; Wen L
J Obstet Gynaecol; 2024 Dec; 44(1):2333784. PubMed ID: 38602239
[TBL] [Abstract] [Full Text] [Related]
18. Hyperpolarized [1-
Lin G; Hsieh CY; Lai YC; Wang CC; Lin Y; Lu KY; Chai WY; Chen AP; Yen TC; Ng SH; Lai CH
Eur Radiol Exp; 2024 Apr; 8(1):46. PubMed ID: 38594558
[TBL] [Abstract] [Full Text] [Related]
19. Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).
Sheth SS; Oh JE; Bellone S; Siegel ER; Greenman M; Mutlu L; McNamara B; Pathy S; Clark M; Azodi M; Altwerger G; Andikyan V; Huang G; Ratner E; Kim DJ; Iwasaki A; Levi AW; Buza N; Hui P; Flaherty S; Schwartz PE; Santin AD
Clin Cancer Res; 2024 May; 30(9):1768-1777. PubMed ID: 38592381
[TBL] [Abstract] [Full Text] [Related]
20. A Comparative Study of Deep Learning Dose Prediction Models for Cervical cancer Volumetric Modulated Arc Therapy.
Wu Z; Liu M; Pang Y; Deng L; Yang Y; Wu Y
Technol Cancer Res Treat; 2024; 23():15330338241242654. PubMed ID: 38584413
[No Abstract] [Full Text] [Related]
[Next]